Efficacy and Safety of Livalozet® in Hypercholesterolemic Patients With and Without Diabetes

Study of MB07811 in Subjects With Hypercholesterolemia

NCT00879112 ·Status: WITHDRAWN ·Phase: PHASE2

Study of Oral MD-0727 Administered to Patients With Primary Hypercholesterolemia

NCT00404001 ·Status: COMPLETED ·Phase: PHASE2

A Phase II Study To Evaluate the Efficacy And Safety Of HRS-1301 In Participants With Dyslipidemia

NCT07229937 ·Status: RECRUITING ·Phase: PHASE2

A Study of LY3015014 in Healthy Participants With Elevated Low Density Lipoprotein Cholesterol

NCT01426412 ·Status: COMPLETED ·Phase: PHASE1

Comparison of Intensive Versus Standard Care & Education for Dyslipidemia in Hypertension and Diabetes Patients

NCT07045623 ·Status: RECRUITING ·Phase: NA

Specified Drug-use Survey of Leqvio for s.c. Injection.

NCT06275724 ·Status: ACTIVE_NOT_RECRUITING

A Study to Look at How Safe a New Medicine (NNC0491-6075) is in Healthy People and in Participants With High Levels of Fat in the Blood

NCT05979428 ·Status: COMPLETED ·Phase: PHASE1

A Clinical Trial for Evaluation of Adequate Dose and Safety of DW-3102 in Hypercholesterolemia Patients

NCT02368613 ·Status: UNKNOWN ·Phase: PHASE2

Effect of LIMICOL®-NG on Plasma LDL-cholesterol Concentration in Subjects with Moderate Hypercholesterolemia

NCT06894251 ·Status: RECRUITING ·Phase: NA

Optimizing Statin Tratment in People Living With Diabetes

NCT04320719 ·Status: COMPLETED

DLBS1449 in Diabetic Patients With Low HDL

NCT01972477 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3

Efficacy and Safety of Alirocumab Versus Placebo on Top of Maximally Tolerated Lipid Lowering Therapy in Patients With Hypercholesterolemia Who Have Type 1 or Type 2 Diabetes and Are Treated With Insulin (ODYSSEY DM - Insulin)

NCT02585778 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of Lapaquistat Acetate in Subjects Currently Treated With Lipid-Lowering Therapy.

NCT00251680 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of JS002 as Monotherapy in Patients With Primary Hypercholesterolaemia and Mixed Dyslipidemia

NCT05621070 ·Status: RECRUITING ·Phase: PHASE3

INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers

NCT03273972 ·Status: COMPLETED ·Phase: NA

Adult Subjects With Elevated Low-Density Lipoprotein-Cholesterol to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects

NCT05905068 ·Status: COMPLETED ·Phase: PHASE1

Choline Fenofibrate and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia

NCT05365425 ·Status: RECRUITING ·Phase: PHASE4

Safety, Tolerability, PK and PD of LGT209 in Healthy Volunteers and Patients With Hypercholesterolemia

NCT01979601 ·Status: COMPLETED ·Phase: PHASE1

LIFESTAT - Living With Statins, a Cross Sectional Study

NCT02250677 ·Status: COMPLETED

Reduction of Low-Density Lipoprotein Cholesterol (LDL-C) With PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder Study

NCT01375751 ·Status: COMPLETED ·Phase: PHASE2

Clinical Trial to Evaluate the Safety, Pharmacokinetic Characteristics of DW5124 and DW5124-R, and the Effect of Food on DW5124 in Healthy Adult Volunteers

NCT07319559 ·Status: COMPLETED ·Phase: PHASE1

Safety of Lapaquistat Acetate in Subjects With Hypercholesterolemia

NCT00868127 ·Status: COMPLETED ·Phase: PHASE3

Phase 1 to Evaluate the Safety and Pharmacokinetic Characteristics of Fixed-dose Combination of YYC506

NCT04874129 ·Status: UNKNOWN ·Phase: PHASE1

Phase 3 Trial to Evaluate the Efficacy and Safety of YYC506.

NCT04858308 ·Status: UNKNOWN ·Phase: PHASE3

Bioavailability Study of DP-R202 in Healthy Male Volunteers Under Fed Conditions

NCT01421576 ·Status: COMPLETED ·Phase: PHASE1